closure of Trading Window Disclosure
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has informed the stock exchanges that its trading window will be closed from Wednesday, 1 April 2026. The closure applies to all designated persons, employees, directors, promoters, key managerial personnel, and their immediate relatives. The window will reopen 48 hours after the company declares its audited financial results for the quarter and year ended 31 March 2026. The board meeting date to approve these results will be communicated separately. This is a routine insider trading compliance measure under SEBI (PIT) Regulations, 2015.
No direct impact on shareholders. This is a standard regulatory disclosure ahead of the FY26 audited results announcement, and signals that the results could come anytime after 1 April 2026 once the board approves them.